Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Find the latest information on COVID-19, monkeypox, and the flu vaccine

GRADED NEUROLOGIC SCALE FOR USE IN ACUTE HEMISPHERIC STROKE TREATMENT PROTOCOLS STROKE Adams, R. J., Meador, K. J., Sethi, K. D., Grotta, J. C., Thomson, D. S. 1987; 18 (3): 665-669

Abstract

A standardized neurologic assessment scoring instrument was developed and tested for use in a multicenter trial of hypervolemic hemodilution in acute hemispheric stroke. Components of the neurologic examination pertinent to hemispheric stroke syndromes were emphasized. The scale was evaluated using 16 acute stroke patients for concurrent validity (Pearson coefficient r = 0.89 compared with global assessments by neurologists or neurosurgeons) and interobserver reliability (r = 0.95 interobserver reliability estimate). Such a scale should prove useful in quantifying neurologic deficits in hemispheric stroke and in following changes in neurologic status during multicenter acute treatment protocols.

View details for Web of Science ID A1987H714200023

View details for PubMedID 3109080